Brain Tumor Research Highlights: July 2017 Cover photo courtesy of the National Cancer Institute (NCI) Over the years, NBTS has given more than $35 million to brain tumor research projects. We’re very proud of the impact this funding has made in advancing the neuro-oncology field closer to better treatments and ultimately a cure. And while NBTS is currently focused on driving our […] July 24, 2017
[INFOGRAPHIC] Defeat GBM By The Numbers At the end of June, we published our 2017 Defeat GBM Research Collaborative Progress Report (PDF). Accompanying this comprehensive report on the impact of this flagship research program, were a blog recapping the cumulative progress being made – from discovery to drug screening – as well as a press release announcing the important results from the […] July 18, 2017
Defeat GBM-Funded Research Helps Reveal Another Astonishing Trick Brain Tumors Play Summary: A surprising, counter-intuitive discovery by Defeat GBM Research Collaborative-funded researchers opens up a potential new approach to slowing glioblastoma (GBM) growth We all learn during grade school math that when doing multiplication, “a negative times (x) a negative equals a positive.” Could this be true for glioblastoma tumor biology, too? A new study from […] May 12, 2017
Brain Tumor Research Highlights: April 2017 Cover photo courtesy of the National Cancer Institutes (NCI) Over the years, NBTS has given more than $35 million to brain tumor research projects. We’re very proud of the impact this funding has made in advancing the neuro-oncology field closer to better treatments and ultimately a cure. And while NBTS is currently focused on driving our […] April 25, 2017
National Brain Tumor Society Funding and Support of Innovative Research Helps Bring About an Immunotherapy Clinical Trial With Encouraging Results Today, encouraging results from a small, early-stage clinical trial for glioblastoma patients were reported in the scientific and medical journal, Clinical Cancer Research. The phase one study of 11 newly diagnosed glioblastoma (GBM) patients showed that combining an experimental immunotherapy with chemotherapy (temozolomide), along with an injection to prime the immune system, was well tolerated […] April 14, 2017